DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/13846
Title: Curative effect of kangfuyan capsule combined with antibiotic treatment on pelvic inflammatory disease
Authors: Wang, Lu
Chen, Yi
Ouyang, Yin-Luan
Wang, Feng-Wei
Zhang, Run-Ju
Chen, Xiao
Keywords: Kangfuyan capsule
Pelvic inflammatory disease
damp-heat and blood stasis type
Curative effect
Issue Date: 15-Nov-2021
Publisher: Karachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.
Citation: Ting, L., Li-Ying, W. U., Xiao-Mei, Y., Yao, C., Xue-Jiao, D. U., Xue-Dan, L., ... & Wen-Ting, Z. (2021). Curative effect of kangfuyan capsule combined with antibiotic treatment on pelvic inflammatory disease. Pakistan Journal of Pharmaceutical Sciences, 34(6 (Special)), 2479-2485.
Abstract: This study aims to investigate the curative effect of Kangfuyan capsule in the treatment of damp-heat and blood stasis type of pelvic inflammatory disease (PID), and its influence on serum inflammatory factors IL-6, CRP and TNF-α. A total of 83 patients with PID were randomly divided into two groups: Western medicine group (control group, n=41) received oral antibiotics (azithromycin + metronidazole) alone and the traditional Chinese medicine combined with Western medicine group (experimental group, n=42) received Kangfuyan capsule based on Western medicine therapy. Clinical efficacy between these two groups and the influence of drugs in serum inflammatory factors (IL-6, CRP and TNF-α) were compared. The total effective rate was 78.05% in the control group and 97.62% in the experimental group and difference between these two groups was statistically significant (P<0.01). The symptoms and signs in the two groups significantly improved after treatment (P<0.05) and improvement rate was significantly better in the experimental group than in the control group (P<0.05). After treatment, serum inflammatory factor levels in the two groups were significantly lower than levels before treatment (P<0.05) and improvement rate was significantly better in the experimental group than in the control group (P<0.05). Kangfuyan capsule combined with antibiotics can effectively relieve the symptoms and signs of patients, improve the efficiency of treatment, provide high safety, and does not increase adverse reactions.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/13846
ISSN: 1011-601X
Appears in Collections:Issue 6 (Special)

Files in This Item:
File Description SizeFormat 
15-9396-SP.htm141 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.